category

Earnings Report

UBS reports 22-percent drop in 4Q net amid tax effects

Swiss bank UBS has reported a 22-percent drop in net income in the fourth quarter last year, due in part to tax effects, but says rising investor confidence in the United States could boost its wealth management business.

UBS reports 22-percent drop in 4Q net amid tax effects

Swiss bank UBS has reported a 22-percent drop in net income in the fourth quarter last year, due in part to tax effects, but says rising investor confidence in the United States could boost its wealth management business.

Intel Posts Stronger-Than-Expected Results

Intel Corp.'s fourth-quarter profit slipped 1.4%, despite robust sales of chips that drive the computers underpinning large internet providers and corporate operations, while sales of chips for PCs also rose.

Intel Posts Stronger-Than-Expected Results

Intel Corp.'s fourth-quarter profit slipped 1.4%, despite robust sales of chips that drive the computers underpinning large internet providers and corporate operations, while sales of chips for PCs also rose.

Starbucks Sales Disappoint

Starbucks Corp reported a smaller-than-expected rise in quarterly sales at established restaurants in its U.S.-dominated Americas region amid a persistent restaurant slump.

Starbucks Sales Disappoint

Starbucks Corp reported a smaller-than-expected rise in quarterly sales at established restaurants in its U.S.-dominated Americas region amid a persistent restaurant slump.

J&J to buy Swiss biopharma firm Actelion for $30 billion

Johnson & Johnson is buying Swiss biopharmaceutical company Actelion Ltd. for about $30 billion, handing the U.S.-based health care products giant a chance to boost its presence in innovative biotech treatments.

J&J to buy Swiss biopharma firm Actelion for $30 billion

Johnson & Johnson is buying Swiss biopharmaceutical company Actelion Ltd. for about $30 billion, handing the U.S.-based health care products giant a chance to boost its presence in innovative biotech treatments.